IONpath Competitors and Similar CompaniesClear all
IONpath's competitors and similar companies include MILabs, Kem-En-Tec Nordic, Curasight and Nirmidas Biotech.
 Curasight Curasight is a company engaged in the field of exploiting a Positron Emissions Tomography (PET) imaging platform targeting the urokinase-type plasminogen activator receptor (uPAR). |  Nirmidas Biotech Nirmidas Biotech is a company that develops and manufactures biological testing, assays, and imaging products and services. | ||||
Founding Date | Founding Date 2014 | Founding Date 2006 | Founding Date 1987 | Founding Date 2013 | Founding Date 2013 |
Type | Type Private | Type Private | Type Private | Type Private | Type Private |
Tags | |||||
Locations | Locations Menlo Park, US HQ | Locations Houten, NL HQ | Locations Taastrup, DK HQ | Locations København, DK HQ | Locations Mountain View, US HQ |
Employees | Employees 166% decrease | Employees 542% increase | Employees 16 | Employees 7 | Employees 7 |
Funding | |||||
Latest funding round | Latest funding round $ 18m (over 5 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 2m (over 11 years ago) |
Total funding raised | Total funding raised $ 18m | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 2m |
For sources of this data, please see the company profile
View Company Profiles
MILabs
HQ
Houten, NL
Employees
54↑ 2% increase
MILabs is a company that develops molecular imaging solutions for biomedical research.
View companyCurasight
HQ
København, DK
Employees
7
Curasight is a company engaged in the field of exploiting a Positron Emissions Tomography (PET) imaging platform targeting the urokinase-type plasminogen activator receptor (uPAR).
View companyNirmidas Biotech
HQ
Mountain View, US
Employees
7
Nirmidas Biotech is a company that develops and manufactures biological testing, assays, and imaging products and services.
View company